Allaire Manon, Bruix Jordi, Korenjak Marko, Manes Sarah, Maravic Zorana, Reeves Helen, Salem Riad, Sangro Bruno, Sherman Morris
AP-HP Sorbonne Université, Hôpital Universitaire Pitié-Salpêtrière, Service d'Hépato-gastroentérologie, Paris, France.
University Hospital Clinic IDIBAPS, Barcelona, Spain.
JHEP Rep. 2022 Sep 8;4(12):100578. doi: 10.1016/j.jhepr.2022.100578. eCollection 2022 Dec.
Hepatocellular carcinoma (HCC) is a major public health problem worldwide for which the incidence and mortality are similar, pointing to the lack of effective treatment options. Knowing the different issues involved in the management of HCC, from risk factors to screening and management, is essential to improve the prognosis and quality of life of affected individuals. This document summarises the current state of knowledge and the unmet needs for all the different stakeholders in the care of liver cancer, meaning patients, relatives, physicians, regulatory agencies and health authorities so that optimal care can be delivered to patients. The document was commissioned by the International Liver Cancer Association and was reviewed by senior members, including two ex-presidents of the Association. This document lays out the recommended approaches to the societal management of HCC based on the economic status of a given region.
肝细胞癌（HCC）是一个全球性的重大公共卫生问题，其发病率和死亡率相近，这表明缺乏有效的治疗选择。了解HCC管理中涉及的不同问题，从风险因素到筛查和管理，对于改善受影响个体的预后和生活质量至关重要。本文总结了肝癌护理中所有不同利益相关者（即患者、亲属、医生、监管机构和卫生当局）的当前知识状态和未满足的需求，以便能够为患者提供最佳护理。该文件由国际肝癌协会委托编写，并由包括协会两位前主席在内的资深成员进行了审阅。本文根据特定地区的经济状况，列出了HCC社会管理的推荐方法。
